Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 89.48%-25.55K | -39.38%-132.37K | 62.84%-43.15K | -596.6K | -140.22%-142.7K | 17.88%-242.82K | -206.68%-94.97K | 21.59%-116.12K | 0 | 354.75K |
| Net income from continuing operations | -4.02%-185.27K | 11.46%-145.85K | 88.95%-172.11K | -1,537.01%-2.11M | -195.00%-211.84K | 12.96%-178.11K | -79.75%-164.73K | -2,693.72%-1.56M | ---129.03K | --223K |
| Remuneration paid in stock | --0 | --0 | --34.06K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cashItems | ---- | ---- | ---- | --1.43M | --0 | --0 | --0 | --1.43M | ---- | ---- |
| Change In working capital | 346.82%159.71K | -80.67%13.49K | 524.60%94.9K | -30.72%89.4K | -47.52%69.15K | 28.93%-64.71K | -61.39%69.76K | 116.45%15.19K | --129.03K | --131.76K |
| -Change in receivables | 94.71%-4.34K | --0 | -82.22%12K | ---12K | --15.65K | ---82.11K | ---13.05K | --67.5K | --0 | --0 |
| -Change in prepaid assets | 127.30%27.08K | 4.30%33.38K | 273.39%39.83K | -102.39%-3.58K | -64.70%52.96K | ---99.21K | --32K | --10.67K | --150K | --150K |
| -Change in payables and accrued expense | 17.46%136.97K | -139.15%-19.89K | 168.39%43.07K | -18.64%104.98K | -99.59%537 | 228.07%116.61K | -71.88%50.81K | 31.80%-62.98K | --129.03K | --131.76K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 89.48%-25.55K | -39.38%-132.37K | 62.84%-43.15K | ---596.6K | -140.22%-142.7K | 17.88%-242.82K | -206.68%-94.97K | 21.59%-116.12K | --0 | --354.75K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 195.17%370.47K | 0 | 0 | 0 | 370.47K | -389.26K | -389.26K |
| Net other investing changes | ---- | ---- | ---- | 195.17%370.47K | --0 | --0 | --0 | --370.47K | ---389.26K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 195.17%370.47K | --0 | --0 | --0 | --370.47K | ---389.26K | ---389.26K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -92.91%24.58K | 322.33%125.29K | 142.19%42.64K | -39.43%235.76K | 35.06%46.61K | 17.21%346.58K | 36.70%-56.36K | -168.25%-101.07K | 389.26K | 34.51K |
| Net common stock issuance | ---- | ---- | ---- | 47.75%575.13K | -77.39%88K | ---- | ---- | ---- | --389.26K | --389.26K |
| Proceeds from stock option exercised by employees | --9 | --0 | --6 | --3 | --3 | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | 117.48%24.57K | 322.33%125.29K | 142.18%42.64K | -200.36%-339.38K | -149.63%-41.39K | -147.54%-140.55K | 36.70%-56.36K | -168.25%-101.07K | --338.17K | ---16.58K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -92.91%24.58K | 322.33%125.29K | 142.19%42.64K | -39.43%235.76K | 35.06%46.61K | 17.21%346.58K | 36.70%-56.36K | -168.25%-101.07K | --389.26K | --34.51K |
| Net cash flow | ||||||||||
| Beginning cash position | 4.92%2.05K | -94.05%9.12K | --9.63K | --0 | --105.71K | --1.95K | --153.28K | --0 | 0.00%10 | --0 |
| Current changes in cash | -100.94%-971 | 95.32%-7.08K | -100.33%-502 | --9.63K | ---96.09K | --103.76K | ---151.33K | --153.28K | ---- | ---- |
| End cash Position | -98.98%1.08K | 4.92%2.05K | -94.05%9.12K | 96,160.00%9.63K | 96,160.00%9.63K | --105.71K | --1.95K | --153.28K | 0.00%10 | --10 |
| Free cash from | 89.48%-25.55K | -39.38%-132.37K | 62.84%-43.15K | ---596.6K | -140.22%-142.7K | 17.88%-242.82K | -206.68%-94.97K | 21.59%-116.12K | --0 | --354.75K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.